Literature DB >> 23153612

Implications of OSA on Work and Work Disability Including Drivers.

Ann Y Teng1, Christine Won.   

Abstract

This article illustrates the impact of obstructive sleep apnea (OSA) on the work force and emphasizes that there are public health risks and significant societal financial losses in untreated OSA. Specifics of OSA impact on individuals are discussed with regard to veterans, first responders, farmers, and pilots, specially focusing on commercial vehicle drivers. The pathophysiology of OSA and the consequence of impairment and disability due to OSA on work capacity are introduced. Federal guidelines for occupational-specific recommendations are presented. The health care provider's role in identifying and incorporating effective screening and treatment strategies for workers with sleep apnea is emphasized.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23153612     DOI: 10.1016/j.ccm.2012.09.003

Source DB:  PubMed          Journal:  Clin Chest Med        ISSN: 0272-5231            Impact factor:   2.878


  3 in total

1.  Validated Measures of Insomnia, Function, Sleepiness, and Nasal Obstruction in a CPAP Alternatives Clinic Population.

Authors:  Austin S Lam; Nancy A Collop; Donald L Bliwise; Raj C Dedhia
Journal:  J Clin Sleep Med       Date:  2017-08-15       Impact factor: 4.062

2.  Obstructive sleep apnea and driving: A Canadian Thoracic Society and Canadian Sleep Society position paper.

Authors:  Najib Ayas; Robert Skomro; Adam Blackman; Kristen Curren; Michael Fitzpatrick; John Fleetham; Charles George; Tom Hakemi; Patrick Hanly; Christopher Li; Debra Morrison; Frédéric Series
Journal:  Can Respir J       Date:  2014 Mar-Apr       Impact factor: 2.409

3.  Forced expiratory volume in one second: A novel predictor of work disability in subjects with suspected obstructive sleep apnea.

Authors:  Mariarita Stendardo; Valeria Casillo; Michela Schito; Licia Ballerin; Francesco Stomeo; Emanuela Vitali; Marco Nardini; Elisa Maietti; Piera Boschetto
Journal:  PLoS One       Date:  2018-07-19       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.